Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Children as young as 4 years old are capable of finding efficient solutions to complex problems, such as independently inventing sorting algorithms developed by computer scientists. The scientists ...

Just this past school year, I attended a meeting with my department administrator, reviewing teacher observation data. The numbers didn’t lie—but they didn’t tell the full story. Despite our best ...

So, you want to get good at LeetCode, especially using Java? It’s a common goal for a lot of us trying to land those tech jobs. This guide is all about helping you get there. We’ll go over how to ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

MicroAlgo Inc. announced its research on the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to address complex combinatorial optimization problems using quantum computing.

(RTTNews) - Recursion (RXRX) posted a net loss of $178.9 million for the fourth quarter of 2024, compared to a net loss of $93.0 million for the fourth quarter of 2023. Net loss per share was $0.53 ...

The original version of this story appeared in Quanta Magazine. Computer scientists often deal with abstract problems that are hard to comprehend, but an exciting new algorithm matters to anyone who ...